Lost password ?
<< Back to Equity Research
Dallah Healthcare
DALLAH IS NOT YET ATTRACTIVE
Aug 15 - Dallah Healthcare (Sell, Saudi Arabia) has rather stopped its euphoric rally and the stock has corrected slightly in recent months but it is still in its high levels. The stock price was up by 0.68% ...
Executive summary
Conflict of Interest
Pages 38
Language English
Publish on August 15, 2023
€ 500
VAT Exl.
You might be also interested by these reports :
Apr 29 PM
Idea Kicker
MOUWASAT MEDICAL, A HEALTHY GROWTH STORY BUT EXPE...
Apr 08 AM
Mouwasat Medical
Target pushed up by strong results
Mar 26 AM
Dallah Healthcare
Target boosted by a strong outlook
Mar 26 AM
Mouwasat Medical
Mouwasat Medical increases its net profit by 10%
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ